Upcoming FDA decision · October 6, 2026
Atacicept PDUFA date: FDA decision expected October 6, 2026
13 days to goVera Therapeutics, Inc. (VERA) →
The FDA is expected to decide on Atacicept from Vera Therapeutics, Inc. in IgA Nephropathy (IgAN) by the PDUFA target action date of October 6, 2026. For IgA nephropathy. NDA filing. Extracted from SEC filing: 8-K
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
October 6
Target action date
Phase 3
Stage
Detected
Date confidence
—
FDA designations